FIELD: bioengineering.
SUBSTANCE: fused polypeptide is produced coded by a nucleic acid and containing the following elements in the 5'→ 3' direction, i.e. i) the nucleic acid encoding the polypeptide, ii) the nucleic acid encoding amino acid sequence SEQ ID NO: 01, and the nucleic acid encoding a Strep-tag. Then, the fused polypeptide produced at the previous step is incubated with target-polypeptide, having sequence SEQ ID NO: 02, which is covalently conjugated with poly(ethyleneglycol) fragment at a lysine C-end residue and with a trypsin mutant form D189K, K60E, Na143H, E151H. Then, it is extracted to get the polypeptide conjugated with one poly(ethyleneglycol) fragment.
EFFECT: production of a monoPEGilinated polypeptide.
11 cl, 4 dwg, 5 tbl, 3 ex
Title |
Year |
Author |
Number |
STABILISED INSULIN-LIKE GROWTH FACTOR POLYPEPTIDES |
2007 |
- Glass Dejvid Dzhonatan
- Fornaro Mara
|
RU2477287C2 |
IMPROVED METHODS OF PRODUCING RECOMBINANT POLYPEPTIDE |
2014 |
- Kopetski Erkhard
- Nivener Ens
- Majer Peter
|
RU2711322C1 |
RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM |
2006 |
|
RU2412253C2 |
POLYPEPTIDES MODULATING SIGLEC-DEPENDENT IMMUNE RESPONSES |
2017 |
- Kannicht, Christoph
- Winge, Stefan
- Kohla, Guido
- Solecka-Witulska, Barbara
|
RU2776807C2 |
NOVEL SOLUBLE POLYPEPTIDES CD83, COMPOSITIONS AND METHODS OF THEIR APPLICATION |
2009 |
- Brand Stefen
- Chou Chikh-Khsiun
- Moo-Joung Mjurrej
|
RU2535340C2 |
POLYPEPTIDES OF DIRECTED ACTION |
2006 |
- Rozenbljum Majkl G.
- Cheung Lorens
- Liu Mi-Ae
|
RU2393874C2 |
EXPRESSION OF NITROGENASE POLYPEPTIDES IN PLANT CELLS |
2020 |
- Allen, Robert Silas
- Gregg, Christina Maria
- Okada, Shoko
- Menon, Amratha
- Warden, Andrew Charles
- Taylor, Matthew Craig
- Wood, Craig Christopher
|
RU2833880C2 |
METHODS AND COMPOSITION FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES |
2010 |
- Marrichi Mettyu
- Rejlli Doroteya E.
|
RU2585488C2 |
NOVEL METHODS OF ENZYME-MEDIATED CONJUGATION OF POLYPEPTIDES USING SORTASE |
2015 |
- Benits-Dulat Mara
- Kratssh Peter
- Shatte Martin
|
RU2714963C2 |
APPLICATION OF FUSED POLYPEPTIDE CONTAINING MeCP2 PROTEIN AND PROTEIN TRANSDUCTION DOMAIN, PHARMACEUTICAL COMPOSITION CONTAINING SUCH PROTEIN AND METHOD OF TREATING AND/OR PREVENTING DEVELOPMENTARY NEUROPATHY |
2006 |
|
RU2432359C2 |